[
  {
    "type": "user_query",
    "content": "There is an author who studied and worked in both Nepal and USA. What is the name of the company (as of January 2012) that he worked for in Nepal where he worked as a Biotechnologist? The author published an article along with 8 other authors and it was published in PubMed during the year 2021. The research for this article was supported by the funding from National Institutes of Health."
  },
  {
    "type": "token_usage",
    "step": 1,
    "total_tokens": 706
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 2,
    "total_tokens": 686
  },
  {
    "type": "plan",
    "content": "I need to identify an author with a specific profile who published a NIH-funded article in 2021. Let me approach this systematically:\n\n1. First, I'll search for PubMed articles from 2021 that have NIH funding and involve authors affiliated with Nepal institutions\n2. Once I find potential articles, I'll examine the author list (looking for 9 total authors) and check their affiliations\n3. Then I'll investigate each author's background to see who worked as a biotechnologist in Nepal at a company as of January 2012\n4. Finally, I'll verify their educational/work history to confirm they studied/worked in both Nepal and USA\n\nLet me start with a search combining these key elements."
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly, choose exactly ONE action tag: \n1) <search>query</search> to search for information \n2) <access>url</access> to access a specific URL \n3) <answer>final answer</answer> to provide your final answer"
  },
  {
    "type": "token_usage",
    "step": 3,
    "total_tokens": 814
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 4,
    "total_tokens": 1122
  },
  {
    "type": "plan",
    "content": "I need to identify a specific author who meets multiple criteria:\n- Studied and worked in both Nepal and USA\n- Worked as a Biotechnologist in Nepal for a company (as of January 2012)\n- Published a 2021 PubMed article with 8 other authors (9 total)\n- The article was NIH-funded\n\nMy search strategy:\n1. Search for PubMed articles from 2021 that mention NIH funding and have Nepal affiliations\n2. Look for articles with exactly 9 authors\n3. Examine author affiliations and backgrounds to find the matching profile\n4. Verify the author's work history in Nepal as a biotechnologist for a company in January 2012\n\nI'll start with a targeted search combining PubMed, 2021, Nepal, and NIH funding keywords."
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly, choose exactly ONE action tag: \n1) <search>query</search> to search for information \n2) <access>url</access> to access a specific URL \n3) <answer>final answer</answer> to provide your final answer"
  },
  {
    "type": "token_usage",
    "step": 5,
    "total_tokens": 1329
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 6,
    "total_tokens": 1874
  },
  {
    "type": "plan",
    "content": "I need to identify an author with specific criteria:\n- Studied and worked in both Nepal and USA\n- Worked as a Biotechnologist in Nepal for a company (as of January 2012)\n- Published a 2021 PubMed article with 8 other authors (9 total)\n- The article was NIH-funded\n\nFrom my search results, I found several promising leads:\n1. \"Dried blood blot-based mass spectrometry screening of hemoglobin variants\" - had Nepal affiliations but only 2-3 authors\n2. \"Global Landscape of SARS-CoV-2 Genome Surveillance\" - had 35 authors, too many\n3. \"Emergence and dissemination of mcr-9 blaNDM-1 in multidrug-resistant clones\" - had multiple Nepal institutions\n4. Other articles that could potentially match\n\nMy next step is to access specific URLs to examine the detailed author information. I need to look for:\n- Articles with exactly 9 authors total\n- Author affiliations mentioning Nepal\n- Any author background information that could indicate they worked as a biotechnologist in Nepal\n\nI'll start by accessing the most promising article that had multiple Nepal affiliations."
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly, choose exactly ONE action tag: \n1) <search>query</search> to search for information \n2) <access>url</access> to access a specific URL \n3) <answer>final answer</answer> to provide your final answer"
  },
  {
    "type": "token_usage",
    "step": 7,
    "total_tokens": 2047
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 8,
    "total_tokens": 2182
  },
  {
    "type": "plan",
    "content": "I found a promising article \"Multiple Introduction and Sparse Genomic Surveillance of the SARS-CoV-2 Beta Variant in Nepal\" that:\n- Was published in 2021\n- Has NIH funding acknowledgment\n- Has multiple authors\n- Is Nepal-related\n\nNow I need to examine this article in detail to check:\n1. If it has exactly 9 authors total\n2. The author affiliations and backgrounds\n3. Whether any author matches the profile: studied/worked in both Nepal and USA, worked as a biotechnologist in Nepal for a company as of January 2012\n\nI'll access the full PMC article to get the complete author list and any biographical information that could help identify the target author."
  },
  {
    "type": "access",
    "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450879/"
  },
  {
    "type": "access_observation_raw",
    "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450879/",
    "raw_text": "Extract Results:\n\n(No results returned)"
  },
  {
    "type": "token_usage",
    "step": 9,
    "total_tokens": 2092
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 10,
    "total_tokens": 2420
  },
  {
    "type": "plan",
    "content": "I need to find a specific author who matches the criteria:\n- Studied and worked in both Nepal and USA\n- Worked as a Biotechnologist in Nepal for a company (as of January 2012)\n- Published a 2021 PubMed article with 8 other authors (9 total)\n- The article was NIH-funded\n\nSince my previous searches didn't yield the exact match, I'll try a different approach:\n1. Search for Nepal researchers who published in PubMed in 2021\n2. Look for articles with exactly 9 authors\n3. Check author affiliations more carefully\n4. Look for any biographical information that mentions biotechnology work in Nepal\n\nI'll search more broadly for Nepal researchers in PubMed 2021 first."
  },
  {
    "type": "search",
    "query": "Nepal researchers PubMed 2021 author affiliation"
  },
  {
    "type": "token_usage",
    "step": 11,
    "total_tokens": 3871
  },
  {
    "type": "plan",
    "content": "My previous searches haven't identified the specific author yet. I need to try a different approach. Let me search more specifically for:\n\n1. Biotechnology companies in Nepal that might have employed researchers\n2. Nepalese researchers who have worked both in Nepal and USA\n3. Look for any author biographical information that mentions working as a biotechnologist\n\nI'll try searching for \"biotechnologist Nepal company\" to see if I can find any specific companies or researchers that match this profile."
  },
  {
    "type": "search",
    "query": "biotechnologist Nepal company \"January 2012\""
  },
  {
    "type": "token_usage",
    "step": 12,
    "total_tokens": 4770
  },
  {
    "type": "plan",
    "content": "I need to be more systematic about finding this specific author. Let me try a different approach:\n\n1. Search specifically for NIH-funded research projects in Nepal in 2021\n2. Look for articles with exactly 9 authors\n3. Examine each author's background and affiliations more carefully\n4. Check if any author biographical information mentions working as a biotechnologist in Nepal\n\nLet me search for NIH-funded Nepal research 2021 with a focus on finding articles with 9 authors."
  },
  {
    "type": "search",
    "query": "\"NIH\" \"funded\" \"Nepal\" \"2021\" \"PubMed\" \"9 authors\""
  },
  {
    "type": "token_usage",
    "step": 13,
    "total_tokens": 6822
  },
  {
    "type": "plan",
    "content": "I need to find a specific author with these criteria:\n- Studied and worked in both Nepal and USA\n- Worked as a Biotechnologist in Nepal for a company (as of January 2012)\n- Published a 2021 PubMed article with 8 other authors (9 total)\n- The article was NIH-funded\n\nLet me try searching for biotechnology companies in Nepal first, then look for their employees who might have published research in 2021. This approach might help me identify the company and then the specific author."
  },
  {
    "type": "search",
    "query": "biotechnology companies Nepal employees researchers"
  },
  {
    "type": "token_usage",
    "step": 14,
    "total_tokens": 7911
  },
  {
    "type": "plan",
    "content": "I found several biotechnology research organizations in Nepal, including RIBB (Research Institute for Bioscience & Biotechnology) which was founded in 2011. Since the question mentions \"as of January 2012,\" RIBB could be the company in question.\n\nMy next step is to search for:\n1. Authors who worked at RIBB and published research in 2021\n2. NIH-funded articles from 2021 with authors affiliated with RIBB\n3. Any author biographical information that mentions working as a biotechnologist\n\nLet me search specifically for RIBB and PubMed 2021 to find the connection."
  },
  {
    "type": "search",
    "query": "RIBB \"Research Institute for Bioscience & Biotechnology\" PubMed 2021"
  },
  {
    "type": "token_usage",
    "step": 15,
    "total_tokens": 8039
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 16,
    "total_tokens": 8327
  },
  {
    "type": "plan",
    "content": "I need to find an author who matches very specific criteria:\n- Studied and worked in both Nepal and USA\n- Worked as a Biotechnologist in Nepal for a company (as of January 2012)\n- Published a 2021 PubMed article with 8 other authors (9 total)\n- The article was NIH-funded\n\nMy strategy so far:\n1. Searched for Nepal-related PubMed articles from 2021\n2. Looked at NIH-funded research in Nepal\n3. Explored biotechnology companies in Nepal like RIBB\n4. Searched for author biographical information\n\nSince I haven't found the exact match, let me try a different approach - searching specifically for authors who have worked in both Nepal and USA, as this combination might be more distinctive and help me identify the right person."
  },
  {
    "type": "search",
    "query": "\"Nepal\" \"USA\" author researcher biotechnologist 2021"
  },
  {
    "type": "token_usage",
    "step": 17,
    "total_tokens": 9413
  },
  {
    "type": "plan",
    "content": "I found several Nepalese researchers with USA connections, including Dr. Niraj Aryal who has worked at both University of Wisconsin-Madison and University of Florida. Let me try a more systematic approach:\n\n1. Search for NIH-funded PubMed articles from 2021 that include authors from Nepal institutions\n2. Look specifically for articles with exactly 9 authors\n3. Check each author's background to see if any worked as a biotechnologist in Nepal around January 2012\n4. Focus on finding the company where they worked as a biotechnologist\n\nLet me search more specifically for NIH-funded research involving Nepal in 2021."
  },
  {
    "type": "search",
    "query": "\"funded by National Institutes of Health\" Nepal 2021 PubMed"
  },
  {
    "type": "token_usage",
    "step": 18,
    "total_tokens": 9808
  },
  {
    "type": "plan",
    "content": "I need to find a very specific author profile. Let me try searching more specifically for:\n\n1. Authors who explicitly worked as \"biotechnologists\" in Nepal\n2. Biotechnology companies or research institutes in Nepal that might have employed such researchers\n3. Nepalese researchers who have US connections and published NIH-funded research in 2021\n\nThe key might be to search for the exact combination of \"biotechnologist\" and \"Nepal\" and \"company\" in relation to researchers who published in 2021."
  },
  {
    "type": "search",
    "query": "\"biotechnologist\" Nepal company author researcher"
  },
  {
    "type": "token_usage",
    "step": 19,
    "total_tokens": 10298
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 20,
    "total_tokens": 10532
  },
  {
    "type": "plan",
    "content": "I need to find a very specific author profile. Let me try a more targeted approach:\n\n1. Search for well-known biotechnology research institutes in Nepal that existed in 2012\n2. Look for their employees who published research in 2021\n3. Check if any of those publications were NIH-funded and had exactly 9 authors\n4. Verify the author's background to see if they worked in both Nepal and USA\n\nSince I found RIBB (Research Institute for Bioscience & Biotechnology) was founded in 2011, this could be the company in question. Let me search more specifically for RIBB employees who published NIH-funded research in 2021."
  },
  {
    "type": "search",
    "query": "\"Research Institute for Bioscience & Biotechnology\" Nepal NIH 2021"
  },
  {
    "type": "token_usage",
    "step": 21,
    "total_tokens": 11584
  },
  {
    "type": "plan",
    "content": "I need to find the specific author and company. Let me try a different approach:\n\n1. Search for PubMed articles from 2021 that have exactly 9 authors and include NIH funding statements\n2. Look for articles with any Nepal connections or affiliations\n3. Once I find the article, examine the author list and affiliations\n4. Check if any author has the profile of working in both Nepal and USA as a biotechnologist\n\nLet me search for articles with exactly 9 authors from 2021 that mention NIH funding."
  },
  {
    "type": "search",
    "query": "PubMed 2021 \"9 authors\" \"National Institutes of Health\" funding"
  },
  {
    "type": "token_usage",
    "step": 22,
    "total_tokens": 12146
  },
  {
    "type": "plan",
    "content": "I need to find a very specific combination of details. Let me try searching for prominent biotechnology companies in Nepal that existed in 2012, and then look for their employees who published research in 2021. \n\nThe key elements I'm searching for:\n- A biotechnology company in Nepal operational as of January 2012\n- An employee who worked as a Biotechnologist there\n- This person studied/worked in both Nepal and USA\n- Published a 2021 PubMed article with 9 authors total that was NIH-funded\n\nLet me search for major biotechnology companies in Nepal that might fit this profile."
  },
  {
    "type": "search",
    "query": "biotechnology companies Nepal \"2012\" \"research\" \"PubMed\""
  },
  {
    "type": "token_usage",
    "step": 23,
    "total_tokens": 13158
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 24,
    "total_tokens": 13402
  },
  {
    "type": "plan",
    "content": "I need to identify a specific author with multiple criteria:\n- Worked as a Biotechnologist in Nepal for a company (as of January 2012)\n- Studied and worked in both Nepal and USA  \n- Published a 2021 PubMed article with 8 other authors (9 total)\n- The article was NIH-funded\n\nI found RIBB (Research Institute for Bioscience & Biotechnology) which was founded in 2011 and operational in January 2012, making it a strong candidate for the company in question.\n\nMy next approach:\n1. Search for specific researchers who worked at RIBB\n2. Look for their 2021 publications with NIH funding\n3. Verify they studied/worked in both Nepal and USA\n4. Check for exactly 9 authors on their 2021 paper\n\nLet me try searching for specific RIBB researchers who published in 2021."
  },
  {
    "type": "search",
    "query": "RIBB \"Research Institute for Bioscience & Biotechnology\" researcher author 2021"
  },
  {
    "type": "token_usage",
    "step": 25,
    "total_tokens": 13552
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 26,
    "total_tokens": 13821
  },
  {
    "type": "plan",
    "content": "I found Prajwal Rajbhandari who is a cofounder/president at RIBB (Research Institute for Bioscience & Biotechnology) and identifies as a biotechnologist. RIBB was founded in 2011, so it would have been operational as of January 2012.\n\nThis looks promising because:\n1. RIBB was operational in January 2012\n2. Prajwal works as a biotechnologist there\n3. He's listed as a cofounder/president, indicating significant involvement\n\nNow I need to:\n1. Check if Prajwal Rajbhandari has any 2021 PubMed publications with exactly 9 authors\n2. Verify the publication was NIH-funded\n3. Confirm he has connections to both Nepal and USA\n4. Establish that he worked as a biotechnologist at RIBB as of January 2012\n\nLet me search specifically for his publications."
  },
  {
    "type": "search",
    "query": "Prajwal Rajbhandari biotechnology Nepal USA author researcher"
  },
  {
    "type": "token_usage",
    "step": 27,
    "total_tokens": 14521
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 28,
    "total_tokens": 14823
  },
  {
    "type": "plan",
    "content": "I found Prajwal Rajbhandari who appears to match several key criteria:\n\n1. ✓ Works as a Biotechnologist at RIBB (Research Institute for Bioscience & Biotechnology)\n2. ✓ RIBB was founded in 2011, so operational as of January 2012\n3. ✓ International education through sandwich program involving Kathmandu University and Sun Moon University\n4. ✓ Was founding Vice President at RIBB from July 2011-December 2017, so working there as of January 2012\n\nHowever, I still need to verify:\n- Whether he has any 2021 PubMed publications with exactly 9 authors\n- If the publication was NIH-funded\n- Any USA connections (his education was in South Korea, not USA)\n\nLet me access his RIBB profile page to get more detailed information about his publications and background."
  },
  {
    "type": "access",
    "url": "https://ribb.org.np/prajwal-rajbhandari/"
  },
  {
    "type": "access_observation_raw",
    "url": "https://ribb.org.np/prajwal-rajbhandari/",
    "raw_text": "Extract Results:\n\n1. URL: https://ribb.org.np/prajwal-rajbhandari/\nRaw Content:\n## Prajwal Rajbhandari\n\n* [Home](https://ribb.org.np \"Home\")\n* Prajwal Rajbhandari\n\n# Prajwal Rajbhandari\n\nCo-Founder, President\n\n* [[email protected]](/cdn-cgi/l/email-protection)\n* Sarlahi, Nepal\n\nIntroduction\n\nResearch Expertise\n\nProfessional Experiences:\n\nMr. Rajbhandari, who hails from Sarlahi, Nepal, obtained his master's degree in Biotechnology in 2010 through a sandwich program involving Kathmandu University (KU) in Nepal and the Institute of Biomolecule Reconstruction (iBR) at Sun Moon University in South Korea. He initially served as the founding Vice President for six and a half years before becoming the President in January 2018 at the Research Institute for Bioscience and Biotechnology in Nepal. Among his accolades are the Nepal Vidya Bhushan \"Kha\" (2011), the National Energy Globe Award (2015), and the Elsevier Foundation Green and Sustainable Chemistry Challenge (2018). His research focuses on natural preservatives, traditional fermented food systems, and gut microbiome. In addition to his research, he enjoys engaging with local communities through public engagement programs related to food microbiology and probiotics.\n\n* [Faecal pollution source tracking in the holy Bagmati River by portable 16S rRNA gene sequencing](https://www.nature.com/articles/s41545-021-00099-1)\n* [Patterns and determinants of the global herbivorous mycobiome](https://www.nature.com/articles/s41467-023-39508-z)\n* [The genetic demographic history of the last hunter-gatherer population of the Himalayas](https://www.nature.com/articles/s41598-024-80156-0)\n* [Effect of altitude and solvent on Psidium guajava Linn. leaves extracts: phytochemical analysis, antioxidant, cytotoxicity and antimicrobial activity against food spoilage microbes](https://link.springer.com/article/10.1186/s13065-023-00948-9)\n* [Harnessing a decade of research at the Research Institute for Bioscience and Biotechnology in Kathmandu, Nepal](https://link.springer.com/article/10.1186/s12919-023-00252-3)\n* [Research institutes from nest eggs: challenges and the way forward](https://www.nature.com/articles/s43586-023-00288-x)\n\n* President at Research Institute for Bioscience and Biotechnology (RIBB) from January 2018 - Until now\n* Founding Vice President at Research Institute for Bioscience and Biotechnology (RIBB) from July 2011 - December 2017\n\n[xe88 apk](http://aceclub6.com/)"
  },
  {
    "type": "token_usage",
    "step": 29,
    "total_tokens": 15692
  },
  {
    "type": "plan",
    "content": "I found Prajwal Rajbhandari who matches several criteria:\n\n1. ✓ Works as a Biotechnologist at RIBB \n2. ✓ RIBB founded July 2011, so operational as of January 2012\n3. ✓ International education (Nepal + South Korea)\n4. ✓ Was founding Vice President at RIBB from July 2011, so working there as of January 2012\n\nFrom his publications list, I see a 2021 Nature article: \"Faecal pollution source tracking in the holy Bagmati River by portable 16S rRNA gene sequencing\"\n\nI need to:\n1. Check this 2021 article for exactly 9 authors\n2. Verify if it was NIH-funded  \n3. Confirm Prajwal Rajbhandari is an author\n4. Look for USA connections (his education was South Korea, not USA, but maybe he worked in USA too)\n\nLet me access this specific article to verify the details."
  },
  {
    "type": "access",
    "url": "https://www.nature.com/articles/s41545-021-00099-1"
  },
  {
    "type": "access_observation_raw",
    "url": "https://www.nature.com/articles/s41545-021-00099-1",
    "raw_text": "Extract Results:\n\n1. URL: https://www.nature.com/articles/s41545-021-00099-1\nRaw Content:\nurl raw content too long, here is the summary:\nThis study, published in *npj Clean Water* in 2021, utilized a portable \"suitcase laboratory\" with 16S rRNA amplicon sequencing to assess microbial water quality and track faecal pollution sources in the holy Bagmati River in Kathmandu, Nepal. The research, conducted during the monsoon (June, July 2019) and post-monsoon (August 2019) seasons, involved sampling six river sites (S1-S6) from Sundarijal (upstream) to Chovar (downstream), as well as influent and effluent from the Guheshwori Wastewater Treatment Plant (WWTP).\n\n**Key Findings:**\n\n*   **Pollution Source:** SourceTracker analysis and Volcano plots revealed that microbial communities in the downstream sections of the Bagmati River (sites S4, S5, S6) were predominantly contributed by untreated sewage (WWTP influent).\n*   **Bacterial Communities:** Upstream sites (S1, S2) were characterized by genera like *Acidovorax, Geobacillus*, and *Caulobacter*. In contrast, downstream sites showed a significant increase in genera containing putative human pathogens and gut bacteria, including *Clostridium, Prevotella, Arcobacter, Lactobacillus, Enterococcus*, and *Streptococcus*.\n*   **Seasonal Variability:** The composition of the sewage microbiome varied seasonally, which was reflected in the downstream river water quality. Different faecal indicator bacteria were more prevalent in different seasons (e.g., *Prevotella* and *Arcobacter* in monsoon; *Enterococcus* and *Streptococcus* in post-monsoon).\n*   **qPCR Confirmation:** Marker gene qPCR assays for total bacteria, total coliforms, Human *E. coli*, *Arcobacter butzleri*, and *Vibrio cholerae* confirmed the trends observed in the sequencing data, showing significantly higher concentrations of these genes downstream.\n*   **Treatment Inadequacy:** The microbial water quality of the downstream Bagmati River was often similar to or worse than untreated sewage (WWTP influent), and substantially poorer than WWTP effluent, highlighting the impact of direct discharge of untreated sewage.\n*   **Validation:** The portable MinION sequencing results were validated through correlation with qPCR data for specific faecal marker genes and traditional Most Probable Number (MPN) tests for coliform bacteria.\n\n**Context and Implications:**\n\nThe Bagmati River is culturally and religiously significant, flowing through the Kathmandu Valley and past the Pashupatinath Temple (a World Heritage Site). It serves as a source of drinking water, irrigation, and religious bathing. However, rapid urbanization, population growth, unmanaged sewage connections (approximately 21,000 kg of domestic sewage and 3151 kg of industrial BOD discharged daily), and solid waste disposal have severely polluted the river. This pollution poses a significant public health risk, contributing to waterborne diseases like typhoid and cholera, and affecting groundwater quality and vegetables grown with polluted water.\n\nThe study demonstrates the practical feasibility of using a portable MinION NGS platform for rapid, comprehensive microbial water quality monitoring and faecal pollution source tracking in resource-limited settings. The findings underscore the urgent need for improved wastewater management in Kathmandu, as current sanitation provisions are insufficient. The data provides a baseline for evaluating the environmental benefits of ongoing projects, such as the Asian Development Bank's Kathmandu Valley Wastewater Management Project, which aims to expand and modernize wastewater treatment facilities. This approach supports the UN Sustainable Development Goal 6 (clean water and sanitation) by providing tools for effective pollution monitoring and intervention design."
  },
  {
    "type": "token_usage",
    "step": 30,
    "total_tokens": 16301
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 31,
    "total_tokens": 16400
  },
  {
    "type": "plan",
    "content": "I found the 2021 Nature article by Prajwal Rajbhandari about the Bagmati River. Now I need to verify:\n\n1. If this article has exactly 9 authors total\n2. If it was NIH-funded \n3. If Prajwal Rajbhandari worked in USA (so far I only know he studied in South Korea)\n\nLet me search for the full author list and funding information for this specific article."
  },
  {
    "type": "search",
    "query": "\"Faecal pollution source tracking in the holy Bagmati River\" authors list 2021"
  },
  {
    "type": "token_usage",
    "step": 32,
    "total_tokens": 17070
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 33,
    "total_tokens": 17324
  },
  {
    "type": "plan",
    "content": "I found Prajwal Rajbhandari who matches most criteria:\n\n1. ✓ Works as a Biotechnologist at RIBB (Research Institute for Bioscience & Biotechnology)\n2. ✓ RIBB founded July 2011, operational as of January 2012  \n3. ✓ International education (Nepal + South Korea)\n4. ✓ Founding Vice President from July 2011, so working there as of January 2012\n5. ✓ Published 2021 Nature article about Bagmati River\n\nStill need to verify:\n- If the article has exactly 9 authors\n- If it was NIH-funded\n- USA connections (only South Korea found so far)\n\nI'm accessing the ResearchGate page to get the complete author list and funding information."
  },
  {
    "type": "access",
    "url": "https://www.researchgate.net/publication/349457579_Faecal_pollution_source_tracking_in_the_holy_Bagmati_River_by_portable_16S_rRNA_gene_sequencing"
  },
  {
    "type": "access_observation_raw",
    "url": "https://www.researchgate.net/publication/349457579_Faecal_pollution_source_tracking_in_the_holy_Bagmati_River_by_portable_16S_rRNA_gene_sequencing",
    "raw_text": "Extract Results:\n\n(No results returned)"
  },
  {
    "type": "token_usage",
    "step": 34,
    "total_tokens": 17178
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 35,
    "total_tokens": 17598
  },
  {
    "type": "plan",
    "content": "I found Prajwal Rajbhandari who appears to match most criteria:\n\n1. ✓ Works as a Biotechnologist at RIBB (Research Institute for Bioscience & Biotechnology)\n2. ✓ RIBB founded in 2011, operational as of January 2012\n3. ✓ International education (Nepal + South Korea)\n4. ✓ Founding Vice President from July 2011, so working there as of January 2012\n5. ✓ Published 2021 Nature article about Bagmati River\n\nStill need to verify:\n- If the article has exactly 9 authors\n- If it was NIH-funded\n- USA connections (only South Korea found so far)\n\nI'm now accessing the Nature article page to get the complete author list and funding information."
  },
  {
    "type": "access",
    "url": "https://www.nature.com/articles/s41545-021-00099-1"
  },
  {
    "type": "access_observation_raw",
    "url": "https://www.nature.com/articles/s41545-021-00099-1",
    "raw_text": "Extract Results:\n\n1. URL: https://www.nature.com/articles/s41545-021-00099-1\nRaw Content:\nurl raw content too long, here is the summary:\nThis study utilized a portable \"suitcase laboratory\" equipped with Oxford Nanopore Technologies (ONT) MinION 16S rRNA gene amplicon sequencing to assess microbial water quality and track faecal pollution sources in the Bagmati River, Kathmandu, Nepal. The research, conducted in 2019 during monsoon (June 7, July 20) and post-monsoon (August 30) seasons, involved sampling six river sites (S1-S6) along a 25 km stretch from Sundarijal (upstream) to Chovar (downstream), as well as influent and effluent from the Guheshwori Wastewater Treatment Plant (WWTP).\n\n**Key Findings:**\n\n*   **Severe Faecal Contamination:** Microbial communities in the downstream sections of the Bagmati River (sites S4, S5, S6) were predominantly contributed by untreated sewage, as revealed by SourceTracker analysis and Volcano plots. This indicates that inadequate wastewater management transforms the urban river into an open sewer, posing a significant public health risk.\n*   **Microbial Community Shift:**\n    *   Upstream sites (S1, S2) were dominated by bacterial genera like *Acidovorax, Geobacillus*, and *Caulobacter*.\n    *   Downstream sites showed a significant increase in genera containing putative human pathogens and gut bacteria, including *Clostridium, Prevotella, Arcobacter, Lactobacillus, Enterococcus*, and *Streptococcus*.\n*   **Seasonal Variability:** The composition of the sewage microbiome varied seasonally, directly impacting downstream river water quality.\n    *   In the monsoon season, *Arcobacter, Aeromonas, Streptococcus*, and *Prevotella* were prominent human gut-associated genera.\n    *   In the post-monsoon season, *Enterococcus, Acinetobacter, Streptococcus*, and *Trichococcus* were more prevalent. This highlights the need to consider seasonal variations when selecting faecal indicators for Microbial Source Tracking (MST).\n*   **Source Tracking Results:**\n    *   **Monsoon:** Upstream river (S1) contributed 63% to S2. Sites S3, S4, and S5 received significant contributions from both upstream river (30-35%) and untreated sewage (23-49%). Site S6 was largely dominated by untreated sewage (72.7%).\n    *   **Post-Monsoon:** Sites S4 (74.66%), S5 (62.73%), and S6 (83.71%) were overwhelmingly constituted by sequences found in WWTP influent (untreated sewage). Upstream river (S1) contributed 77.91% to S2 and 32.65% to S3.\n    *   Approximately 76.63% of faecal waste in the Kathmandu Valley is discharged untreated into water bodies.\n*   **qPCR Validation:** Marker gene qPCR assays for total bacteria, total coliforms, Human *E. coli*, *Arcobacter butzleri*, and *Vibrio cholerae* confirmed the trends observed in the sequencing data.\n    *   Pathogen/faecal marker genes were detected in WWTP influent/effluent and significantly higher in downstream sites (S4-S6) compared to upstream sites and WWTP effluent (p<0.05).\n    *   Human *E. coli* was detected in most locations, while *Vibrio cholerae* (*ompW* gene) was found at S2 and S3 during the monsoon.\n    *   WWTP effluent showed significantly reduced levels of total bacteria, Human *E. coli*, and *Arcobacter butzleri* compared to influent (p<0.05), demonstrating the benefits of treatment.\n*   **Conventional Microbiology:** Most Probable Number (MPN) tests confirmed the presence of coliform bacteria at all sites and *E. coli* at downstream sites, further supporting faecal pollution.\n*   **Public Health Implications:** The Bagmati River, a culturally and religiously significant site where hundreds of thousands of Hindu pilgrims perform bathing rituals, is heavily polluted downstream of the Pashupatinath Temple. This poses a direct exposure pathway for waterborne diseases (e.g., typhoid, cholera, dysentery) to bathers and indirect exposure to residents through contaminated shallow wells and irrigated vegetables.\n\n**Significance:**\n\nThis study is the first to report water microbiomes sequenced in Nepal using a portable MinION platform. It demonstrates the practical feasibility of comprehensive, near-real-time microbial water quality monitoring and faecal pollution source tracking in resource-limited settings. The data provide a crucial baseline for evaluating the environmental benefits of ongoing infrastructure projects, such as the Kathmandu Valley Wastewater Management Project, which aims to expand wastewater treatment capacity from 16 million to 90.5 million liters per day. The application of portable sequencing technologies is vital for achieving UN Sustainable Development Goal (SDG) 6: Clean Water and Sanitation, particularly SDG 6.3, by identifying and reducing pollution sources."
  },
  {
    "type": "token_usage",
    "step": 36,
    "total_tokens": 18736
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 37,
    "total_tokens": 18759
  },
  {
    "type": "plan",
    "content": "I found Prajwal Rajbhandari who matches most criteria for the author:\n\n1. ✓ Works as a Biotechnologist at RIBB (Research Institute for Bioscience & Biotechnology)\n2. ✓ RIBB founded July 2011, operational as of January 2012\n3. ✓ International education (Nepal + South Korea) \n4. ✓ Published 2021 article about Bagmati River\n\nStill need to verify:\n- If the article has exactly 9 authors\n- If it was NIH-funded\n- USA connections (only South Korea found so far)\n\nI need to access the PubMed version of this article to get the complete author list and funding information."
  },
  {
    "type": "search",
    "query": "PubMed \"Faecal pollution source tracking in the holy Bagmati River\" 2021"
  },
  {
    "type": "token_usage",
    "step": 38,
    "total_tokens": 19591
  },
  {
    "type": "plan",
    "content": "I found Prajwal Rajbhandari who appears to be the author I'm looking for:\n\n1. ✓ Works as a Biotechnologist at RIBB (Research Institute for Bioscience & Biotechnology)\n2. ✓ RIBB founded July 2011, operational as of January 2012\n3. ✓ International education (Nepal + South Korea)\n4. ✓ Published 2021 Nature article about Bagmati River\n\nHowever, I need to verify:\n- If Prajwal Rajbhandari is actually an author on the 2021 article (search shows \"K Pantha et al.\")\n- If the article has exactly 9 authors total\n- If it was NIH-funded\n- USA connections (only South Korea found so far)\n\nI need to access the full article to see the complete author list and funding information."
  },
  {
    "type": "access",
    "url": "https://www.nature.com/articles/s41545-021-00099-1"
  },
  {
    "type": "access_observation_raw",
    "url": "https://www.nature.com/articles/s41545-021-00099-1",
    "raw_text": "Extract Results:\n\n1. URL: https://www.nature.com/articles/s41545-021-00099-1\nRaw Content:\nurl raw content too long, here is the summary:\nThis study utilized a portable \"suitcase laboratory\" equipped with Oxford Nanopore Technologies (ONT) MinION 16S rRNA gene amplicon sequencing to assess microbial water quality and track faecal pollution sources in the Bagmati River, Kathmandu, Nepal. The research, conducted in 2019 during monsoon (June 7, July 20) and post-monsoon (August 30) seasons, involved sampling six river sites (S1-S6) along a 25 km stretch from Sundarijal (upstream) to Chovar (downstream), as well as influent and effluent from the Guheshwori Wastewater Treatment Plant (WWTP).\n\n**Key Findings:**\n\n*   **Severe Faecal Contamination:** Microbial communities in the downstream sections of the Bagmati River (sites S4, S5, S6) were predominantly contributed by untreated sewage, as revealed by SourceTracker analysis and Volcano plots. This indicates that inadequate wastewater management transforms the urban river into an open sewer, posing a significant public health risk.\n*   **Microbial Community Shift:**\n    *   Upstream sites (S1, S2) were dominated by bacterial genera like *Acidovorax, Geobacillus*, and *Caulobacter*.\n    *   Downstream sites showed a significant increase in genera containing putative human pathogens and gut bacteria, including *Clostridium, Prevotella, Arcobacter, Lactobacillus, Enterococcus*, and *Streptococcus*.\n*   **Seasonal Variability:** The composition of the sewage microbiome varied seasonally, directly impacting downstream river water quality.\n    *   In the monsoon season, *Arcobacter, Aeromonas, Streptococcus*, and *Prevotella* were prominent human gut-associated genera.\n    *   In the post-monsoon season, *Enterococcus, Acinetobacter, Streptococcus*, and *Trichococcus* were more prevalent. This highlights the need to consider seasonal variations when selecting faecal indicators for Microbial Source Tracking (MST).\n*   **Source Tracking Results:**\n    *   **Monsoon:** Upstream river (S1) contributed 63% to S2. Sites S3, S4, and S5 received significant contributions from both upstream river (30-35%) and untreated sewage (23-49%). Site S6 was largely dominated by untreated sewage (72.7%).\n    *   **Post-Monsoon:** Sites S4 (74.66%), S5 (62.73%), and S6 (83.71%) were overwhelmingly constituted by sequences found in WWTP influent (untreated sewage). Upstream river (S1) contributed 77.91% to S2 and 32.65% to S3.\n    *   Approximately 76.63% of faecal waste in the Kathmandu Valley is discharged untreated into water bodies.\n*   **qPCR Validation:** Marker gene qPCR assays for total bacteria, total coliforms, Human *E. coli*, *Arcobacter butzleri*, and *Vibrio cholerae* confirmed the trends observed in the sequencing data.\n    *   Pathogen/faecal marker genes were detected in WWTP influent/effluent and significantly higher in downstream sites (S4-S6) compared to upstream sites and WWTP effluent (p<0.05).\n    *   Human *E. coli* was detected in most locations, while *Vibrio cholerae* (*ompW* gene) was found at S2 and S3 during the monsoon.\n    *   WWTP effluent showed significantly reduced levels of total bacteria, Human *E. coli*, and *Arcobacter butzleri* compared to influent (p<0.05), demonstrating the benefits of treatment.\n*   **Conventional Microbiology:** Most Probable Number (MPN) tests confirmed the presence of coliform bacteria at all sites and *E. coli* at downstream sites, further supporting faecal pollution.\n*   **Public Health Implications:** The Bagmati River, a culturally and religiously significant site where hundreds of thousands of Hindu pilgrims perform bathing rituals, is heavily polluted downstream of the Pashupatinath Temple. This poses a direct exposure pathway for waterborne diseases (e.g., typhoid, cholera, dysentery) to bathers and indirect exposure to residents through contaminated shallow wells and irrigated vegetables.\n\n**Significance:**\n\nThis study is the first to report water microbiomes sequenced in Nepal using a portable MinION platform. It demonstrates the practical feasibility of comprehensive, near-real-time microbial water quality monitoring and faecal pollution source tracking in resource-limited settings. The data provide a crucial baseline for evaluating the environmental benefits of ongoing infrastructure projects, such as the Kathmandu Valley Wastewater Management Project, which aims to expand wastewater treatment capacity from 16 million to 90.5 million liters per day. The application of portable sequencing technologies is vital for achieving UN Sustainable Development Goal (SDG) 6: Clean Water and Sanitation, particularly SDG 6.3, by identifying and reducing pollution sources."
  },
  {
    "type": "token_usage",
    "step": 39,
    "total_tokens": 20619
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 40,
    "total_tokens": 20906
  },
  {
    "type": "plan",
    "content": "I found that the 2021 Nature article about the Bagmati River is authored by \"K Pantha et al.\" rather than Prajwal Rajbhandari. This suggests either:\n\n1. Prajwal Rajbhandari is a co-author (not first author), or\n2. K Pantha might be a different author entirely, or  \n3. There might be a connection between K Pantha and Prajwal Rajbhandari\n\nI need to search specifically for \"K Pantha\" to see if this is the author I'm looking for, and verify if there are USA connections and if Prajwal Rajbhandari worked as a biotechnologist at RIBB as of January 2012."
  },
  {
    "type": "search",
    "query": "K Pantha author Nepal biotechnology RIBB USA"
  },
  {
    "type": "token_usage",
    "step": 41,
    "total_tokens": 21813
  },
  {
    "type": "plan",
    "content": "Perfect! I found the connection between Kalyan Pantha and Prajwal Rajbhandari in the 2021 Nature article:\n\n1. ✓ Kalyan Pantha is the first author\n2. ✓ Prajwal Rajbhandari is listed as a co-author\n3. ✓ Both are affiliated with RIBB (Research Institute for BIOScience and Biotechnology)\n\nThis confirms RIBB is the company, and the article has at least 2 authors. Now I need to verify:\n\n1. If Kalyan Pantha worked as a biotechnologist at RIBB as of January 2012\n2. If Kalyan Pantha has USA connections (studied/worked in USA)\n3. If the article has exactly 9 authors total\n4. If the article was NIH-funded\n\nLet me search for Kalyan Pantha's specific background information."
  },
  {
    "type": "search",
    "query": "Kalyan PanTHA biotechnologist RIBB USA background"
  },
  {
    "type": "token_usage",
    "step": 42,
    "total_tokens": 22218
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 43,
    "total_tokens": 22433
  },
  {
    "type": "plan",
    "content": "I found Kalyan Pantha who is:\n\n1. ✓ Co-author on the 2021 Nature article about Bagmati River\n2. ✓ Affiliated with RIBB (Research Institute for Bioscience and Biotechnology)\n3. ✓ Works as an Environmentalist and Water Chemist\n\nNow I need to verify:\n- If he worked as a biotechnologist at RIBB as of January 2012\n- If he has USA connections (I see he's now at Federation University in Australia)\n- If the article has exactly 9 authors total\n- If the article was NIH-funded\n\nLet me access his LinkedIn profile to get his complete background information."
  },
  {
    "type": "access",
    "url": "https://np.linkedin.com/in/kalyan-pantha-4ba60858"
  },
  {
    "type": "access_observation_raw",
    "url": "https://np.linkedin.com/in/kalyan-pantha-4ba60858",
    "raw_text": "Extract Results:\n\n(No results returned)"
  },
  {
    "type": "token_usage",
    "step": 44,
    "total_tokens": 22502
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 45,
    "total_tokens": 22690
  },
  {
    "type": "plan",
    "content": "I found two promising authors:\n\n1. Prajwal Rajbhandari - Biotechnologist at RIBB, international background (Nepal + South Korea)\n2. Kalyan Pantha - Co-author on 2021 Nature article, affiliated with RIBB\n\nI still need to verify:\n- If the article has exactly 9 authors total\n- If it was NIH-funded  \n- If either author worked as biotechnologist at RIBB as of January 2012\n- USA connections\n\nLet me search specifically for the complete author list and funding information of the 2021 Nature article about the Bagmati River."
  },
  {
    "type": "search",
    "query": "\"Faecal pollution source tracking in the holy Bagmati River\" author list funding"
  },
  {
    "type": "token_usage",
    "step": 46,
    "total_tokens": 23024
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 47,
    "total_tokens": 23196
  },
  {
    "type": "plan",
    "content": "I need to access the PubMed version of the 2021 article to get the complete author list and funding information. This will help me verify:\n\n1. If the article has exactly 9 authors total\n2. If it was NIH-funded  \n3. Which author worked as biotechnologist at RIBB as of January 2012\n4. Which author has USA connections\n\nLet me search for the PubMed page of this article."
  },
  {
    "type": "search",
    "query": "PubMed \"Faecal pollution source tracking in the holy Bagmati River\" 2021 complete author list"
  },
  {
    "type": "token_usage",
    "step": 48,
    "total_tokens": 23893
  },
  {
    "type": "plan",
    "content": "I'm having difficulty finding the complete author list and funding information for the specific 2021 Nature article. Let me try a different approach and search more broadly for NIH-funded Nepal research from 2021 with exactly 9 authors. Maybe I can find a different article that matches the criteria better.\n\nThe key elements I need to find:\n1. Author who worked as biotechnologist in Nepal for a company as of January 2012\n2. Studied and worked in both Nepal and USA  \n3. Published 2021 PubMed article with exactly 9 authors\n4. The article was NIH-funded\n\nLet me try a broader search approach."
  },
  {
    "type": "search",
    "query": "\"funded by National Institutes of Health\" Nepal 2021 PubMed 9 authors"
  },
  {
    "type": "token_usage",
    "step": 49,
    "total_tokens": 25797
  },
  {
    "type": "plan",
    "content": "I found a promising lead! The search result shows \"Genomic surveillance of SARS-CoV-2 in Nepal\" which:\n\n1. ✓ Has NIH funding (mentioned \"Funding acquisition\")\n2. ✓ Published in 2021 in PMC (PubMed Central)\n3. ✓ Has multiple authors including Rajindra Napit, Scott A Handley, David Wang, Krishna D Manandhar\n\nThis could be the article I'm looking for. I need to access the full article to verify:\n- If it has exactly 9 authors total\n- Complete funding information for NIH confirmation\n- Author affiliations to see if any worked as biotechnologist in Nepal for a company as of January 2012\n- Which author has USA connections\n\nLet me access this article to get the complete details."
  },
  {
    "type": "access",
    "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11636318/"
  },
  {
    "type": "access_observation_raw",
    "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11636318/",
    "raw_text": "Extract Results:\n\n1. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11636318/\nRaw Content:\nurl raw content too long, here is the summary:\nThis study details the genomic surveillance of SARS-CoV-2 in Nepal, analyzing circulating variants during the COVID-19 pandemic.\n\n**Key Findings:**\n*   Out of 278 nasopharyngeal swab samples collected between September 2021 and March 2022, 229 high-quality SARS-CoV-2 genomes were successfully sequenced.\n*   The sequenced genomes revealed significant genomic diversity, with **82.97% (190 samples) identified as Omicron variants** and **17.03% (39 samples) as Delta variants**.\n*   Within the Omicron samples, **94.21% (179/190) were identified as BA.2 and its sub-lineages**. Other Omicron lineages included BA.1.17.2, BA.2.10, BA.2.2, BA.2.3, BA.2.31.1, BA.2.50, BA.2.12.1, BA.2.9, BA.4.2, BA.2.38, BA.2.43, BA.2.78, BA.1.1, and BA.1.\n*   Among the Delta samples, **92.3% (36/39) were identified as B.1.617.2**. Other Delta lineages included AY.4, AY.75, and AY.76.\n*   Phylogenetic analysis demonstrated distinct clustering patterns for the Delta and Omicron variants.\n\n**Methodology:**\n*   **Sample Collection:** 278 nasopharyngeal swab samples were obtained from the National Public Health Laboratory (country-wide) and KM-TU Biotech Covid Lab (Kathmandu) from September 2021 to March 2022.\n*   **RNA Extraction & PCR:** RNA was extracted using a Chemagic Prime Viral RNA kit. SARS-CoV-2-positive samples with Ct values less than 30, confirmed by Real Time Multiplex RT-PCR (Liferiver Novel Coronavirus kit), were selected for sequencing.\n*   **Whole-Genome Sequencing:** The Illumina COVIDSeq protocol was followed, using ARTIC v3 primer pools. Libraries were prepared with \"IDT for Illumina-PCR Indexes,\" quality-checked with Agilent Bioanalyzer, and quantified with Qubit 3.0. Sequencing was performed on an Illumina MiSeq platform (2 × 300 bp paired-end protocol) at IVDRL, Tribhuvan University, Nepal.\n*   **Data Analysis:** The CDC SARS-CoV-2 BFX-UT_ARTIC_Illumina pipeline was used. Reads were mapped to the SARS-CoV-2 reference genome (MN908947.3) using bwa-mem. Consensus genomes (39 complete, 190 nearly complete coding sequences) were generated using iVar (version 1.4.2). Variants were called with iVar and LoFreq (version 2.1.5) and annotated with snpEff and snpSift. Lineages were assigned using Pangolin (version 1.1.14) and NextClade (version 2.14.0). Sequences with more than 3,000 Ns were excluded. A phylogenetic tree was constructed using MAFFT, Augur, and visualized with iTOL.\n\n**Funding and Ethics:**\n*   The study was funded by the United States National Institutes of Health (grant U01AI151810).\n*   Ethical approval was granted by the Nepal Health Research Council (NHRC) (Regd.: 274/2020).\n\n**Data Availability:**\n*   The GenBank accession numbers for the 229 sequences are provided in Table 1 of the article.\n*   Raw reads are available in the SRA database under BioProject number PRJNA1137145, with accession IDs also listed in Table 1.\n\nThis study provides crucial data for understanding and monitoring SARS-CoV-2 variant dynamics in Nepal."
  },
  {
    "type": "token_usage",
    "step": 50,
    "total_tokens": 26906
  },
  {
    "type": "plan",
    "content": "This article about SARS-CoV-2 genomic surveillance in Nepal looks very promising! I found:\n\n1. ✓ Published in 2021 \n2. ✓ Funded by United States National Institutes of Health (grant U01AI151810)\n3. ✓ Has Nepal connections through \"KM-TU Biotech Covid Lab (Kathmandu)\" - this could be the company!\n4. ✓ Multiple authors including Krishna D Manandhar\n\nKey details:\n- Sample collection from \"KM-TU Biotech Covid Lab (Kathmandu)\" - this sounds like the company in question\n- Funding from US NIH (grant U01AI151810) confirms NIH funding\n- Multiple authors involved\n\nI need to:\n1. Get the complete author list to verify exactly 9 authors\n2. Check if any author worked as biotechnologist at a company in Nepal as of January 2012\n3. Look for USA connections among the authors\n4. Confirm which specific company the author worked for\n\nThe article mentions \"KM-TU Biotech Covid Lab\" which could be the company. Let me access the full article to get the complete author list and funding details."
  },
  {
    "type": "search",
    "query": "PMC11636318 author list complete funding"
  },
  {
    "type": "token_usage",
    "step": 51,
    "total_tokens": 27397
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 52,
    "total_tokens": 27495
  },
  {
    "type": "plan",
    "content": "I found a promising article about SARS-CoV-2 genomic surveillance in Nepal that:\n\n1. ✓ Published in 2021\n2. ✓ Funded by United States National Institutes of Health (grant U01AI151810) \n3. ✓ Has Nepal connections through \"KM-TU Biotech Covid Lab (Kathmandu)\"\n4. ✓ Has multiple authors\n\nThis appears to match the criteria. I need to access the full PMC article to get:\n- The complete author list to verify exactly 9 authors\n- Which author worked as biotechnologist at the Nepal company as of January 2012\n- USA connections among authors\n- The specific company name where the author worked as biotechnologist\n\nThe key candidate might be from \"KM-TU Biotech Covid Lab\" which could be the company in question."
  },
  {
    "type": "access",
    "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11636318/"
  },
  {
    "type": "access_observation_raw",
    "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11636318/",
    "raw_text": "Extract Results:\n\n1. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11636318/\nRaw Content:\nurl raw content too long, here is the summary:\nThis study details the genomic surveillance of SARS-CoV-2 in Nepal, analyzing circulating variants during the COVID-19 pandemic.\n\n**Key Findings:**\n*   Out of 278 nasopharyngeal swab samples collected between September 2021 and March 2022, 229 high-quality SARS-CoV-2 genomes were successfully sequenced.\n*   The sequenced genomes revealed significant genomic diversity, with **82.97% (190 samples) identified as Omicron variants** and **17.03% (39 samples) as Delta variants**.\n*   Within the Omicron samples, **94.21% (179/190) were identified as BA.2 and its sub-lineages**. Other Omicron lineages included BA.1.17.2, BA.2.10, BA.2.2, BA.2.3, BA.2.31.1, BA.2.50, BA.2.12.1, BA.2.9, BA.4.2, BA.2.38, BA.2.43, BA.2.78, BA.1.1, and BA.1.\n*   Among the Delta samples, **92.3% (36/39) were identified as B.1.617.2**. Other Delta lineages included AY.4, AY.75, and AY.76.\n*   Phylogenetic analysis demonstrated distinct clustering patterns for the Delta and Omicron variants.\n\n**Methodology:**\n*   **Sample Collection:** 278 nasopharyngeal swab samples were obtained from the National Public Health Laboratory (country-wide) and KM-TU Biotech Covid Lab (Kathmandu) from September 2021 to March 2022.\n*   **RNA Extraction & PCR:** RNA was extracted using a Chemagic Prime Viral RNA kit. SARS-CoV-2-positive samples with Ct values less than 30, confirmed by Real Time Multiplex RT-PCR (Liferiver Novel Coronavirus kit), were selected for sequencing.\n*   **Whole-Genome Sequencing:** The Illumina COVIDSeq protocol was followed, using ARTIC v3 primer pools. Libraries were prepared with \"IDT for Illumina-PCR Indexes,\" quality-checked with Agilent Bioanalyzer, and quantified with Qubit 3.0. Sequencing was performed on an Illumina MiSeq platform (2 × 300 bp paired-end protocol) at IVDRL, Tribhuvan University, Nepal.\n*   **Data Analysis:** The CDC SARS-CoV-2 BFX-UT_ARTIC_Illumina pipeline was used. Reads were mapped to the SARS-CoV-2 reference genome (MN908947.3) using bwa-mem. Consensus genomes (39 complete, 190 nearly complete coding sequences) were generated using iVar (version 1.4.2). Variants were called with iVar and LoFreq (version 2.1.5) and annotated with snpEff and snpSift. Lineages were assigned using Pangolin (version 1.1.14) and NextClade (version 2.14.0). Sequences with more than 3,000 Ns were excluded. A phylogenetic tree was constructed using MAFFT, Augur, and visualized with iTOL.\n\n**Funding and Ethics:**\n*   The study was funded by the United States National Institutes of Health (grant U01AI151810).\n*   Ethical approval was granted by the Nepal Health Research Council (NHRC) (Regd.: 274/2020).\n\n**Data Availability:**\n*   The GenBank accession numbers for the 229 sequences are provided in Table 1 of the article.\n*   Raw reads are available in the SRA database under BioProject number PRJNA1137145, with accession IDs also listed in Table 1.\n\nThis study provides crucial data for understanding and monitoring SARS-CoV-2 variant dynamics in Nepal."
  },
  {
    "type": "token_usage",
    "step": 53,
    "total_tokens": 28512
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 54,
    "total_tokens": 28682
  },
  {
    "type": "plan",
    "content": "I found a promising article about SARS-CoV-2 genomic surveillance in Nepal that matches several criteria:\n\n1. ✓ Published in 2021\n2. ✓ Funded by United States National Institutes of Health (grant U01AI151810) \n3. ✓ Has Nepal connections through \"KM-TU Biotech Covid Lab (Kathmandu)\"\n4. ✓ Has multiple authors\n\nHowever, I still need to verify:\n- The complete author list to confirm exactly 9 authors\n- Which author worked as biotechnologist at a company in Nepal as of January 2012\n- USA connections among authors\n- The specific company name where the author worked as biotechnologist\n\nLet me try to get the full author list by searching specifically for the article with author details."
  },
  {
    "type": "search",
    "query": "PMC11636318 \"Genomic surveillance of SARS-CoV-2 in Nepal\" authors funding"
  },
  {
    "type": "token_usage",
    "step": 55,
    "total_tokens": 29013
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 56,
    "total_tokens": 29122
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 57,
    "total_tokens": 29169
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 58,
    "total_tokens": 29303
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 59,
    "total_tokens": 29476
  },
  {
    "type": "plan",
    "content": "I found Krishna D Manandhar as a key author in the 2021 NIH-funded genomic surveillance article about Nepal. I need to verify:\n\n1. If Krishna D Manandhar worked as a biotechnologist in Nepal for a company as of January 2012\n2. If he has USA connections \n3. The specific company name where he worked\n4. If the article has exactly 9 authors total\n\nLet me try to access the full article through PubMed to get the complete author list and funding information."
  },
  {
    "type": "search",
    "query": "site:pubmed.ncbi.nlm.nih.gov \"Genomic surveillance of SARS-CoV-2 in Nepal\" Krishna Manandhar"
  },
  {
    "type": "token_usage",
    "step": 60,
    "total_tokens": 29668
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 61,
    "total_tokens": 30016
  },
  {
    "type": "plan",
    "content": "I found Krishna D Manandhar as a key author in the 2021 NIH-funded genomic surveillance article about Nepal. This article appears to match several criteria:\n\n1. ✓ Published in 2021\n2. ✓ Funded by United States National Institutes of Health (grant U01AI151810)\n3. ✓ Has Nepal connections\n4. ✓ Krishna D Manandhar is listed as an author\n\nI need to access the PubMed page to get:\n- The complete author list to verify exactly 9 authors\n- Funding confirmation\n- Author affiliations \n- Krishna D Manandhar's background to verify he worked as biotechnologist at a Nepal company as of January 2012\n- USA connections"
  },
  {
    "type": "access",
    "url": "https://pubmed.ncbi.nlm.nih.gov/39530702/"
  },
  {
    "type": "access_observation_raw",
    "url": "https://pubmed.ncbi.nlm.nih.gov/39530702/",
    "raw_text": "Extract Results:\n\n1. URL: https://pubmed.ncbi.nlm.nih.gov/39530702/\nRaw Content:\nurl raw content too long, here is the summary:\nThis study, published in *Microbiol Resour Announc* on December 12, 2024 (Epub November 12, 2024), details the genomic surveillance of SARS-CoV-2 in Nepal.\n\nResearchers sequenced 278 samples collected between September 2021 and March 2022 to identify circulating SARS-CoV-2 variants. From these, 229 high-quality genomes were obtained. The analysis revealed that the Omicron variant accounted for 82.97% of the sequenced samples, while the Delta variant comprised 17.03%. This highlights the genomic diversity of SARS-CoV-2 present in Nepal during that period.\n\nThe study was conducted by a team of authors including Binod Khadka, Rajindra Napit, Kathie A Mihindukulasuriya, and others, affiliated with institutions such as Tribhuvan University (Nepal), Nirvana Biotech (Nepal), Washington University School of Medicine (USA), National Public Health Laboratory (Nepal), and La Jolla Institute for Immunology (USA). The research received funding from the NIH HHS (grants U01 AI151810 and U01AI151810)."
  },
  {
    "type": "token_usage",
    "step": 62,
    "total_tokens": 30367
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 63,
    "total_tokens": 30606
  },
  {
    "type": "plan",
    "content": "I found a very promising lead! The article \"Genomic surveillance of SARS-CoV-2 in Nepal\" has:\n\n1. ✓ Published in 2024 (but research conducted in 2021-2022)\n2. ✓ Funded by NIH HHS (grants U01 AI151810 and U01AI151810)\n3. ✓ Authors include Binod Khadka, Rajindra Napit, Kathie A Mihindukulasuriya, and others\n4. ✓ Affiliated with institutions including Nirvana Biotech (Nepal), Washington University School of Medicine (USA), La Jolla Institute for Immunology (USA)\n\nThe key discovery is \"Nirvana Biotech (Nepal)\" which could be the company in question! Now I need to verify:\n\n1. If Nirvana Biotech existed as of January 2012\n2. If any author worked as a biotechnologist there\n3. If the author has USA connections\n4. If the article has exactly 9 authors total\n\nLet me search specifically for Nirvana Biotech and its connection to the authors."
  },
  {
    "type": "search",
    "query": "Nirvana Biotech Nepal \"Krishna D Manandhar\" \"Binod Khadka\""
  },
  {
    "type": "token_usage",
    "step": 64,
    "total_tokens": 31336
  },
  {
    "type": "plan",
    "content": "I found the complete author list for the \"Genomic surveillance of SARS-CoV-2 in Nepal\" article, but it has more than 9 authors (I count at least 16), which doesn't match the criteria.\n\nHowever, I still need to check if any of these authors:\n1. Worked as a biotechnologist at a Nepal company as of January 2012\n2. Has USA connections\n3. The specific company name\n\nLet me search for specific author backgrounds, particularly focusing on the Nepal-based authors who might have biotechnology industry experience."
  },
  {
    "type": "search",
    "query": "\"Binod Khadka\" Nepal biotechnology company USA background"
  },
  {
    "type": "token_usage",
    "step": 65,
    "total_tokens": 31808
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 66,
    "total_tokens": 31909
  },
  {
    "type": "guidance",
    "content": "Please follow the protocol strictly: \nprovide your thought and planning within <plan>...</plan> tags. This is required.\n"
  },
  {
    "type": "token_usage",
    "step": 67,
    "total_tokens": 32107
  },
  {
    "type": "plan",
    "content": "I'm struggling to find the exact author and company that match all the criteria. Let me try a more systematic approach:\n\n1. Search specifically for PubMed articles from 2021 with exactly 9 authors\n2. Filter for those that mention NIH funding\n3. Look for Nepal affiliations\n4. Then examine each author's background to find one who:\n   - Worked as a biotechnologist in Nepal for a company as of January 2012\n   - Has USA connections\n   - Studied in both Nepal and USA\n\nThis approach might be more effective than working backwards from individual authors."
  },
  {
    "type": "search",
    "query": "PubMed 2021 Nepal \"9 authors\" NIH funded complete author list"
  },
  {
    "type": "token_usage",
    "step": 68,
    "total_tokens": 32697
  },
  {
    "type": "plan",
    "content": "I need to focus on the core question: identifying the biotechnology company in Nepal where an author worked as of January 2012. Let me try a more targeted approach by searching for biotechnology companies in Nepal that were operational in 2012 and then look for their publication records.\n\nI've identified several potential companies:\n- RIBB (Research Institute for Bioscience & Biotechnology) - founded 2011\n- Kathmandu Research Institute for Biological Sciences (KRIBS)\n- Various other research institutes\n\nLet me search specifically for biotechnology companies in Nepal that existed in 2012 and see if any employees published NIH-funded research in 2021."
  },
  {
    "type": "search",
    "query": "\"Research Institute for Bioscience and Biotechnology\" Nepal employees publications 2021"
  },
  {
    "type": "token_usage",
    "step": 69,
    "total_tokens": 33336
  },
  {
    "type": "plan",
    "content": "Based on my extensive search, I've identified RIBB (Research Institute for Bioscience & Biotechnology) as the most likely company that matches the criteria:\n\n1. ✓ RIBB was founded in July 2011, so it was operational as of January 2012\n2. ✓ It's a biotechnology research institute in Nepal\n3. ✓ Prajwal Rajbhandari works there as a biotechnologist\n4. ✓ RIBB has published research and collaborated on international projects\n\nHowever, I need to provide a definitive answer about the company name. RIBB appears to be the primary biotechnology company in Nepal that was operational in January 2012 and fits the profile described in the question.\n\nThe research suggests RIBB was founded in 2011 and has been involved in biotechnology research in Nepal since that time, making it the most likely answer to the question about the company where the author worked as a biotechnologist as of January 2012."
  },
  {
    "type": "answer",
    "content": "Research Institute for Bioscience & Biotechnology (RIBB)"
  }
]